Dia Beta Labs
3 known investors
Dia Beta Labs is a UK-based biotech company developing a pipeline of engineered therapeutic peptides that target beta-cell receptors to treat metabolic diseases such as Type 2 diabetes and obesity. Its candidates aim to preserve and restore pancreatic beta-cell health while supporting weight loss, and are currently in preclinical development.
Investors · 3
Companies House · registry record
View on Companies House ↗- Registered name
- DIA BETA LABS LTD
- Company number
- NI687456
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 13 Apr 2022
- Registered office
- 4 Murray House, Murray Street, Belfast, Antrim, BT1 6DN
- Nature of business (SIC)
- 71200 — Technical testing and analysis72110 — Research and experimental development on biotechnology75000 — Veterinary activities
- Accounts
- last made up to 30 Apr 2025 · next due 31 Jan 2027
- Confirmation statement
- last made up to 12 Apr 2026 · next due 26 Apr 2027
Current officers · 5
- Ryan Alexander Lafferty — secretary, appointed 6 Dec 2022
- Alexander Chacko — director, appointed 6 Dec 2022
- Nigel Irwin — director, appointed 6 Dec 2022
- Ryan Lafferty — director, appointed 13 Apr 2022
- Peter Brian Simpson — director, appointed 6 Dec 2022
Source: Companies House public register · retrieved 9 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.